ArticleFrontiers in immunology2025
Case Report: Acute onset hemiparesis in a young man: do not miss Crohn's disease.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crohn's disease (CD) is a chronic inflammatory bowel disease that may include neurological complications, besides gastrointestinal manifestations. Although cerebrovascular complications are commonly reported, cerebral vasculitis remains an exceedingly rare occurrence and only a limited number of cases have been described. We present the case of a 35-year-old man with CD who presented with acute onset of right-sided hemiparesis, hemiataxia and paresthesias. Laboratory data showed an inflammatory profile. Contrast-enhanced brain magnetic resonance angiography (MRA) with vessel wall imaging well demonstrated focal areas of contrast enhancement in the perforating arteries and distal arterial branches of intracranial vessels, raising the suspicion of a vasculitic process. The patient was then started on high-dose steroid therapy with immediate improvement of the neurological condition. Follow-up brain MRA revealed a significant reduction of the focal contrast-enhancing alterations. If not accurately identified and promptly treated, vasculitic processes may lead to significant disabilities in young patients and should be considered in the differential etiologies of juvenile stroke since symptoms can improve with immunosuppressive treatment. This case highlights the broad spectrum of possible etiologies to be considered in a young patient presenting with an acute onset neurological syndrome and provides a stepwise approach to developing a comprehensive differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.